Answers are grounded in this paper and cite their sources.
The convergence of AI and synthetic biology is revolutionizing biological discovery and engineering. This manuscript examines how AI-driven tools accelerate bioengineering workflows, unlocking innovations in medicine, agriculture, and sustainability. It also addresses dual-use risks, governance gaps, and ethical dilemmas posed by these advancements, proposing strategies for oversight and updated regulations. By exploring opportunities and risks, this work highlights the transformative potential of AI-driven synthetic biology and pathways for responsible development.
No takes yet. Share an insight, caveat, or question.
Groff-Vindman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: